Method of producing infectious reovirus

Details for Australian Patent Application No. 2001275628 (hide)

Owner Oncolytics Biotech Inc.

Inventors Thompson, Bradley G.; Thompson, Bradley G.; Coffey, Matthew C.; Coffey, Matthew C.

Agent Cullen & Co

Pub. Number AU-B-2001275628

PCT Pub. Number WO02/12435

Priority 60224026 10.08.00 US

Filing date 20 July 2001

Wipo publication date 18 February 2002

Acceptance publication date 30 August 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 7/00 (2006.01) Viruses, e.g. bacteriophages

C12N 7/02 (2006.01) Viruses, e.g. bacteriophages - Recovery or purification

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

Event Publications

21 April 2005 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee from Oncolytics Biotech, Inc. to Oncolytics Biotech Inc.

30 August 2007 Application Accepted

  Published as AU-B-2001275628

6 September 2007 Corrigenda

  Applications Accepted - Name Index Under the name Oncolytics Biotech Inc., Application No. 2001275628, under INID (72), correct the co-inventors to read Thompson, Bradley G. and Coffey, Matthew C.

3 January 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001275629

2001275627